Jiangsu Bioperfectus Technologies Stock Gross Profit
| 688399 Stock | 70.20 0.17 0.24% |
Jiangsu Bioperfectus Technologies fundamentals help investors to digest information that contributes to Jiangsu Bioperfectus' financial success or failures. It also enables traders to predict the movement of Jiangsu Stock. The fundamental analysis module provides a way to measure Jiangsu Bioperfectus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jiangsu Bioperfectus stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 257.7 M | 244.8 M |
Jiangsu | Gross Profit |
Jiangsu Bioperfectus Technologies Company Gross Profit Analysis
Jiangsu Bioperfectus' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Jiangsu Bioperfectus Gross Profit | 3.35 B |
Most of Jiangsu Bioperfectus' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jiangsu Bioperfectus Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Jiangsu Bioperfectus Technologies reported 3.35 B of gross profit. This is 49.56% higher than that of the Biotechnology sector and 252.91% higher than that of the Health Care industry. The gross profit for all China stocks is 87.75% higher than that of the company.
Jiangsu Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jiangsu Bioperfectus' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jiangsu Bioperfectus could also be used in its relative valuation, which is a method of valuing Jiangsu Bioperfectus by comparing valuation metrics of similar companies.Jiangsu Bioperfectus is currently under evaluation in gross profit category among its peers.
Jiangsu Fundamentals
| Return On Equity | -0.0496 | ||||
| Return On Asset | -0.0315 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 2.23 B | ||||
| Shares Outstanding | 56.67 M | ||||
| Shares Owned By Insiders | 49.47 % | ||||
| Shares Owned By Institutions | 0.60 % | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 10.48 X | ||||
| Revenue | 403.18 M | ||||
| Gross Profit | 3.35 B | ||||
| EBITDA | (149.31 M) | ||||
| Net Income | (384.39 M) | ||||
| Total Debt | 164.76 M | ||||
| Book Value Per Share | 57.97 X | ||||
| Cash Flow From Operations | (113.14 M) | ||||
| Earnings Per Share | (2.92) X | ||||
| Number Of Employees | 684 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 4.14 B | ||||
| Total Asset | 3.91 B | ||||
| Retained Earnings | 2.51 B | ||||
| Working Capital | 2.35 B | ||||
| Net Asset | 3.91 B |
About Jiangsu Bioperfectus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jiangsu Bioperfectus Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu Bioperfectus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu Bioperfectus Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Jiangsu Stock
Jiangsu Bioperfectus financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu Bioperfectus security.